CoChat

Critical role of type III interferon in controlling SARS-CoV-2 infection, replication and spread in primary human intestinal epithelial cells

Open access
Stanifer, Megan L., Kee, Carmon, Cortese, Mirko, Triana, Sergio, Mukenhirn, Markus, Kraeusslich, Hans-Georg, Alexandrov, Theodore, Bartenschlager, Ralf, Boulant, Steeve · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
PreprintCited by 40

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Summary: SARS-CoV-2 is an unprecedented worldwide health problem that requires concerted and global approaches to better understand the virus in order to develop novel therapeutic approaches to stop the COVID-19 pandemic and to better prepare against potential future emergence of novel pandemic viruses. Although SARS-CoV-2 primarily targets cells of the lung epithelium causing respiratory infection and pathologies, there is growing evidence that the intestinal epithelium is also infected. However, the importance of the enteric phase of SARS-CoV-2 for virus-induced pathologies, spreading and prognosis remains unknown. Here, using both colon-derived cell lines and primary non-transformed colon organoids, we engage in the first comprehensive analysis of SARS-CoV-2 lifecycle in human intestinal epithelial cells. Our results demonstrate that human intestinal epithelial cells fully support SARS-CoV-2 infection, replication and production of infectious de-novo virus particles. Importantly, we identified intestinal epithelial cells as the best culture model to propagate SARS-CoV-2. We found that viral infection elicited an extremely robust intrinsic immune response where, interestingly, type III interferon mediated response was significantly more efficient at controlling SARS-CoV-2 replication and spread compared to type I interferon. Taken together, our data demonstrate that human intestinal epithelial cells are a productive site of SARS-CoV-2 replication and suggest that the enteric phase of SARS-CoV-2 may participate in the pathologies observed in COVID-19 patients by contributing in increasing patient viremia and by fueling an exacerbated cytokine response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2020.04.24.059667

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 33

  1. Blanco-Melo, D. , Nilsson-Payant, B.E. , Liu, W.-C. , Møller, R. , Panis, M. , Sachs, D. , Albrecht, R.A. , and tenOever, B.R. 2020. SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems (Microbiology). · DOI
  2. 10.1371/journal.ppat.1003773 · DOI · Paper page
  3. 10.1038/s41579-018-0118-9 · DOI · Paper page
  4. 2015, Ultrastructure of the replication sites of positive-strand RNA viruses, Virology, 479–480, 418
  5. Harcourt, J. , Tamin, A. , Lu, X. , Kamili, S. , Sakthivel, S.Kumar. , Murray, J. , Queen, K. , Tao, Y. , Paden, C.R. , Zhang, J. , et al. 2020. Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient (Microbiology). · DOI
  6. Hoffmann, M. , Kleine-Weber, H. , Schroeder, S. , Krüger, N. , Herrler, T. , Erichsen, S. , Schiergens, T.S. , Herrler, G. , Wu, N.-H. , Nitsche, A. , et al. 2020. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 0. · DOI · Paper page
  7. 10.1016/j.gastro.2003.08.001 · DOI · Paper page
  8. Lokugamage, K.G. , Hage, A. , Schindewolf, C. , Rajsbaum, R. , and Menachery, V.D. 2020. SARS-CoV-2 sensitive to type I interferon pretreatment. BioRxiv 2020.03.07.982264.
  9. 10.1002/jmv.25678 · DOI · Paper page
  10. Lukassen, S. , Lorenz Chua, R. , Trefzer, T. , Kahn, N.C. , Schneider, M.A. , Muley, T. , Winter, H. , Meister, M. , Veith, C. , Boots, A.W. , et al. 2020. SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. EMBO J. n/a. · DOI · Paper page
  11. Mantlo, E. , Bukreyeva, N. , Maruyama, J. , Paessler, S. , and Huang, C. 2020. Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection. BioRxiv 2020.04.02.022764. · DOI
  12. Moriyama, M. , Hugentobler, W.J. , and Iwasaki, A. 2020. Seasonality of Respiratory Viral Infections. Annu. Rev. Virol. 7, null. · DOI · Paper page
  13. 10.1128/JVI.79.6.3846-3850.2005 · DOI
  14. 10.1001/jama.2020.0757 · DOI · Paper page
  15. 10.3389/fimmu.2017.00459 · DOI
  16. 10.1371/journal.ppat.1007420 · DOI · Paper page
  17. 10.1073/pnas.1100552108 · DOI · Paper page
  18. 10.1016/j.cell.2019.06.029 · DOI · Paper page
  19. 10.1111/cmi.12626 · DOI
  20. 2020, Asymmetric distribution of TLR3 leads to a polarized immune response in human intestinal epithelial cells, Nat. Microbiol, 5, 181
  21. 10.1128/JVI.01565-07 · DOI · Paper page
  22. Venkatakrishnan, A.J. , Puranik, A. , Anand, A. , Zemmour, D. , Yao, X. , Wu, X. , Chilaka, R. , Murakowski, D.K. , Standish, K. , Raghunathan, B. , et al. 2020. Knowledge synthesis from 100 million biomedical documents augments the deep expression profiling of coronavirus receptors. BioRxiv 2020.03.24.005702. · doi:10.1101/2020.03.24.005702
  23. Wang, L. , and Zhang, Y. 2016. Animal Coronaviruses: A Brief Introduction. In Animal Coronaviruses, L. Wang , ed. (New York, NY: Springer), pp. 3–11. · doi:10.1007/978-1-4939-3414-0_1
  24. 10.1016/j.coviro.2018.12.001 · DOI · Paper page
  25. Wang, W. , Xu, Y. , Gao, R. , Lu, R. , Han, K. , Wu, G. , and Tan, W. 2020. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. · DOI · Paper page
  26. Wölfel, R. , Corman, V.M. , Guggemos, W. , Seilmaier, M. , Zange, S. , Müller, M.A. , Niemeyer, D. , Jones, T.C. , Vollmar, P. , Rothe, C. , et al. 2020. Virological assessment of hospitalized patients with COVID-2019. Nature. · DOI
  27. Wu, C. , Zheng, S. , Chen, Y. , and Zheng, M. (2020a). Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV, in the nasal tissue (Infectious Diseases (except HIV/AIDS)). · DOI
  28. Wu, Y. , Guo, C. , Tang, L. , Hong, Z. , Zhou, J. , Dong, X. , Yin, H. , Xiao, Q. , Tang, Y. , Qu, X. , et al. (2020b). Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol. Hepatol. 0. · DOI · Paper page
  29. Xiao, F. , Tang, M. , Zheng, X. , Liu, Y. , Li, X. , and Shan, H. 2020. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology S0016508520302821. · DOI · Paper page
  30. Xing, Y.-H. , Ni, W. , Wu, Q. , Li, W.-J. , Li, G.-J. , Wang, W.-D. , Tong, J.-N. , Song, X.-F. , Wing-Kin Wong, G. , and Xing, Q.-S. 2020. Prolonged Viral Shedding in Feces of Pediatric Patients with Coronavirus Disease 2019. J. Microbiol. Immunol. Infect. S1684118220300815. · DOI · Paper page
  31. Xu, Y. , Li, X. , Zhu, B. , Liang, H. , Fang, C. , Gong, Y. , Guo, Q. , Sun, X. , Zhao, D. , Shen, J. , et al. (2020b). Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat. Med. 1–4. · DOI · Paper page
  32. 10.1038/s41590-019-0345-x · DOI
  33. 10.1126/sciadv.aao4966 · DOI · Paper page

Cited by

See all 40

Metadata

Authors
Stanifer, M. L., Kee, C., Cortese, M., Triana, S., Mukenhirn, M., Kraeusslich, H.-G., Alexandrov, T., Bartenschlager, R., & Boulant, S.
Venue
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Published
2020-04-24
OpenAlex
W3019118275
Cited by
40
References
4
Type
posted content
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Critical role of type III interferon in controlling SARS-CoV-2 infection, replication and spread in primary human intestinal epithelial cells. https://app.cochat.ai/papers/10.1101/2020.04.24.059667
The paper
Stanifer, M. L., Kee, C., Cortese, M., Triana, S., Mukenhirn, M., Kraeusslich, H.-G., Alexandrov, T., Bartenschlager, R., & Boulant, S. (2020). Critical role of type III interferon in controlling SARS-CoV-2 infection, replication and spread in primary human intestinal epithelial cells. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2020.04.24.059667

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.